Guglielmi Giulia, Krishnathasan Kaushiga, Constantine Andrew, Dimopoulos Konstantinos
Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, United Kingdom.
National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Int J Cardiol Congenit Heart Dis. 2024 Jul 14;17:100527. doi: 10.1016/j.ijcchd.2024.100527. eCollection 2024 Sep.
Cardiac catheterization (CC) is essential for the diagnosis of pulmonary hypertension (PH), and for its characterisation. It allows distinction between pre- and post-capillary PH which, when integrated with other non-invasive data, facilitates classification into one of the 5 diagnostic groups defined by international PH guidelines. CC also provides valuable information for the risk stratification of patients with PH, guiding management and the type and intensity of treatment. Right heart catheterization is usually sufficient in PH practice, yet additional information can be acquired by extending the protocol to include left heart catheterization or provocation protocols. This review provides a detailed overview of diagnostic CC as used in PH practice, including in patients with congenital heart disease, with an emphasis on fundamental concepts, tips and tricks and potential pitfalls.
心脏导管检查(CC)对于肺动脉高压(PH)的诊断及其特征描述至关重要。它能够区分毛细血管前和毛细血管后PH,当与其他非侵入性数据相结合时,有助于将其分类为国际PH指南定义的5个诊断组之一。CC还为PH患者的风险分层提供有价值的信息,指导治疗管理以及治疗的类型和强度。在PH实践中,右心导管检查通常就足够了,但通过扩展方案以包括左心导管检查或激发试验方案,可以获得更多信息。本综述详细概述了PH实践中使用的诊断性CC,包括先天性心脏病患者,重点介绍基本概念、技巧和潜在陷阱。